Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review.
Lubrano E, Spadaro A, Amato G, Benucci M, Cavazzana I, Chimenti MS, Ciancio G, D Alessandro G, Angelis R, Lupoli S, Lurati AM, Naclerio C, Russo R, Semeraro A, Tomietto P, Zuccaro C, De Marco G. Lubrano E, et al. Among authors: semeraro a. Semin Arthritis Rheum. 2015 Apr;44(5):542-550. doi: 10.1016/j.semarthrit.2014.09.012. Epub 2014 Sep 28. Semin Arthritis Rheum. 2015. PMID: 25450240 Review.
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.
Fabris M, Quartuccio L, Vital E, Pontarini E, Salvin S, Fabro C, Zabotti A, Benucci M, Manfredi M, Ravagnani V, Biasi D, Atzeni F, Sarzi-Puttini P, Morassi P, Fischetti F, Bazzicchi L, Saracco M, Pellerito R, Cimmino M, Carraro V, Semeraro A, Schiavon F, Caporali R, Bortolotti R, Govoni M, Fogolari F, Tonutti E, Bombardieri S, Emery P, De Vita S. Fabris M, et al. Among authors: semeraro a. Arthritis Rheum. 2013 Jan;65(1):88-97. doi: 10.1002/art.37707. Arthritis Rheum. 2013. PMID: 23001900 Free article.
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study.
Quartuccio L, Fabris M, Pontarini E, Salvin S, Zabotti A, Benucci M, Manfredi M, Biasi D, Ravagnani V, Atzeni F, Sarzi-Puttini P, Morassi P, Fischetti F, Tomietto P, Bazzichi L, Saracco M, Pellerito R, Cimmino M, Schiavon F, Carraro V, Semeraro A, Caporali R, Cavagna L, Bortolotti R, Paolazzi G, Govoni M, Bombardieri S, De Vita S. Quartuccio L, et al. Among authors: semeraro a. Ann Rheum Dis. 2014 Apr;73(4):716-21. doi: 10.1136/annrheumdis-2012-202435. Epub 2013 Mar 16. Ann Rheum Dis. 2014. PMID: 23505228
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Iannone F, Santo L, Anelli MG, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Carlino G, Casilli O, Cacciapaglia F, Zuccaro C, Falappone PC, Cantatore FP, Muratore M, Lapadula G. Iannone F, et al. Among authors: semeraro a. Semin Arthritis Rheum. 2017 Aug;47(1):108-114. doi: 10.1016/j.semarthrit.2017.01.008. Epub 2017 Jan 18. Semin Arthritis Rheum. 2017. PMID: 28216195
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).
Iannone F, Santo L, Bucci R, Semeraro A, Carlino G, Paoletti F, Quarta L, Leucci P, Zuccaro C, Marsico A, Scioscia C, D'Onofrio F, Mazzotta D, Muratore M, Cantatore FP, Lapadula G. Iannone F, et al. Among authors: semeraro a. Clin Rheumatol. 2018 Mar;37(3):667-675. doi: 10.1007/s10067-018-3989-2. Epub 2018 Feb 7. Clin Rheumatol. 2018. PMID: 29411182
Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
Iannone F, Semeraro A, Carlino G, Santo L, Bucci R, Quarta L, Maruotti N, Zuccaro C, Marsico A, Falappone PCF, Mazzotta D, Cantatore FP, Muratore M, Lapadula G. Iannone F, et al. Among authors: semeraro a. Clin Drug Investig. 2019 Jun;39(6):565-575. doi: 10.1007/s40261-019-00782-9. Clin Drug Investig. 2019. PMID: 30941736
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.
Favalli EG, Conti F, Selmi C, Iannone F, Bucci R, D'Onofrio F, Carlino G, Santo L, Semeraro A, Zuccaro C, D'Angelo S, Atzeni F, Marino F, Monti S, Guidelli GM, Spinelli FR, Biggioggero M, Caporali R. Favalli EG, et al. Among authors: semeraro a. Clin Exp Rheumatol. 2020 Jan-Feb;38(1):19-26. Epub 2019 May 10. Clin Exp Rheumatol. 2020. PMID: 31074721
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
Favalli EG, Becciolini A, Carletto A, Conti F, Amato G, Fusaro E, Quartuccio L, Egan CG, Lo Monaco A, Benucci M, Salaffi F, Semeraro A, Parisi S, Ceccarelli F, Piazza I, Foti R. Favalli EG, et al. Among authors: semeraro a. Rheumatol Int. 2020 Feb;40(2):263-272. doi: 10.1007/s00296-019-04416-3. Epub 2019 Aug 21. Rheumatol Int. 2020. PMID: 31435754
Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE study.
Serban T, Allara R, Azzolini V, Bellintani C, Belloli L, Belai Beyene N, Bucci R, Caporali R, Cappelli A, Corbelli V, DE Gennaro F, Fusaro E, Giusti A, Govoni M, Magnani L, Manzo C, Romano C, Rossini M, Santilli D, Saviola G, Sinigaglia L, Bianchi G; MARTE study group. Serban T, et al. Minerva Med. 2021 Apr;112(2):246-254. doi: 10.23736/S0026-4806.21.06902-0. Epub 2021 Feb 8. Minerva Med. 2021. PMID: 33555152
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study.
Ramonda R, Lorenzin M, Carriero A, Chimenti MS, Scarpa R, Marchesoni A, Lubrano di Scorpaniello E, Salvarani C, Cauli A, Semeraro A, Santo L, Ortolan A, Doria A, Fracassi E, Virelli G, Masia M, Fanizzi R, Visalli E, Amato G, Carletto A, Foti R; on behalf Spondyloartritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”. Ramonda R, et al. Among authors: semeraro a. RMD Open. 2021 Feb;7(1):e001519. doi: 10.1136/rmdopen-2020-001519. RMD Open. 2021. PMID: 33593933 Free PMC article.
71 results